Brady Family Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
1,817
+129
+8% +$132K 0.63% 45
2026
Q1
$1.55M Buy
1,688
+147
+10% +$149K 0.48% 52
2025
Q4
$1.66M Sell
1,541
-8
-0.5% -$7.65K 0.51% 48
2025
Q3
$1.18M Hold
1,549
0.37% 57
2025
Q2
$1.21M Hold
1,549
0.37% 59
2025
Q1
$1.28M Buy
1,549
+2
+0.1% +$1.66K 0.41% 59
2024
Q4
$1.19M Hold
1,547
0.37% 60
2024
Q3
$1.37M Hold
1,547
0.41% 59
2024
Q2
$1.4M Sell
1,547
-30
-2% -$24K 0.45% 54
2024
Q1
$1.23M Sell
1,577
-164
-9% -$117K 0.4% 58
2023
Q4
$1.01M Sell
1,741
-99
-5% -$57.8K 0.35% 63
2023
Q3
$989K Sell
1,840
-245
-12% -$126K 0.38% 61
2023
Q2
$978K Buy
2,085
+2
+0.1% +$839 0.36% 62
2023
Q1
$715K Sell
2,083
-24
-1% -$8.09K 0.28% 70
2022
Q4
$771K Buy
+2,107
New +$747K 0.32% 66

Other funds holding LLY

Brady Family Wealth's LLY Position: Q2 2026 in Review

Brady Family Wealth increased its Eli Lilly (LLY) stake by 7.6% in Q2 2026, buying an estimated $132K and bringing the position to 1,817 shares worth $2.18M. The position accounts for 0.63% of the portfolio, ranked #45.

Brady Family Wealth first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brady Family Wealth held 1,817 shares of Eli Lilly worth $2.18M as of Q2 2026.
  • Brady Family Wealth bought 129 Eli Lilly shares in Q2 2026, an estimated $132K.
  • Eli Lilly made up 0.63% of Brady Family Wealth's portfolio in Q2 2026, its #45 holding.
  • Brady Family Wealth first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brady Family Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.